Awareness, Care & Treatment in Obesity Management (ACTION) Study

Sponsor

Novo Nordisk A/S (Industry)

Overall Status

Completed

CT.gov ID

NCT03223493

Collaborator

(none)

3,767

Enrollment

Location

Actual Duration (Days)

8189.9

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The ACTION (Awareness, Care, and Treatment In Obesity management) study aims to identify perceptions, attitudes, behaviours, and potential barriers to effective obesity care across three respondent types: 1) People with Obesity, 2) Healthcare Providers and 3) Employer Representatives in the US. Data is collected via online surveys using a cross-sectional, US-based stratified sample design.

Condition or Disease	Intervention/Treatment	Phase
Metabolism and Nutrition Disorder Obesity	Other: No treatment given

Study Design

Study Type:

Observational

Actual Enrollment :

3767 participants

Observational Model:

Ecologic or Community

Time Perspective:

Cross-Sectional

Official Title:

Awareness, Care & Treatment in Obesity Management (ACTION) Study

Actual Study Start Date :

Oct 29, 2015

Actual Primary Completion Date :

Nov 12, 2015

Actual Study Completion Date :

Nov 12, 2015

Arms and Interventions

Arm	Intervention/Treatment
People with Obesity General population, respondents are recruited via email and/or phone through an online panel company with which respondents have provided permission to be contacted for research	Other: No treatment given Completion of a questionnaire
Healthcare Providers Health care professionals, respondents will be recruited via email, USPS mail, and/or phone through an online panel company with which respondents have provided permission to be contacted for research purposes or through the AMA Masterfile	Other: No treatment given Completion of a questionnaire
Employer representatives Employers, respondents will be recruited via email, USPS mail, and/or phone through an online panel company with which respondents have provided permission to be contacted for research purposes	Other: No treatment given Completion of a questionnaire

Arm

Intervention/Treatment

People with Obesity

General population, respondents are recruited via email and/or phone through an online panel company with which respondents have provided permission to be contacted for research

Other: No treatment given

Completion of a questionnaire

Healthcare Providers

Health care professionals, respondents will be recruited via email, USPS mail, and/or phone through an online panel company with which respondents have provided permission to be contacted for research purposes or through the AMA Masterfile

Other: No treatment given

Completion of a questionnaire

Employer representatives

Employers, respondents will be recruited via email, USPS mail, and/or phone through an online panel company with which respondents have provided permission to be contacted for research purposes

Other: No treatment given

Completion of a questionnaire

Outcome Measures

Primary Outcome Measures

Awareness with the care and management of obesity among people with obesity [Start of interviews day 1 until day 15]
Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design
Awareness with the care and management of obesity among health care providers [Start of interviews day 1 until day 15]
Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design
Awareness with the care and management of obesity among employer representatives [Start of interviews day 1 until day 15]
Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

GENERAL POPULATION
Agrees to AE reporting
Age at least 18 years
Lives in the US
Current BMI at least 30 kg/sqm
HEALTH CARE PROFESSIONALS
Agrees to AE reporting
Physician and board certified or NP/PA
Facility located in the U.S. and not Vermont
Spends at least 70% of time in direct patient care
Seen at least 100 patients in past month
Seen at least 10 patients in past month needing weight management
In practice 2-35 years
Not competitively employed
Primary Care Providers
Specialty is FP, IM, GP
Less than 50% patients seen for obesity
Obesity Specialists
Obesity medicine or weight loss specialist or at least 50% of patients seen for obesity
In practice 2-35 years
EMPLOYERS
Age at least 18 years
Works in the US
Director, Administrator, CHRO, VP or other title
Responsible for making or influencing decisions about health insurance or health and wellness programs
Company employs 500 or more full-time employees
Believes there is a weight issue at their company
Not competitively employed

Exclusion Criteria:

None

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Novo Nordisk Investigational Site	Honeoye Falls	New York	United States	14472

Sponsors and Collaborators

Novo Nordisk A/S

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Novo Nordisk A/S

ClinicalTrials.gov Identifier:

NCT03223493

Other Study ID Numbers:

INS-4409
U1111-1198-9657

First Posted:

Jul 21, 2017

Last Update Posted:

Jul 19, 2019

Last Verified:

Jul 1, 2019

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Obesity

Nutrition Disorders

Study Results

No Results Posted as of Jul 19, 2019